The European Nanobiocom project, led by INASMET-Tecnalia with the help of others, is working on the regeneration and repair of bone tissue. Seven other bodies, leaders in innovation within this specialism, are also taking part in the project. The goal is to come up with a substitute for bone tissue that can put the bone right and regenerate in such a way that it carries out similar functions as in its natural state. From Spain the Institute of Biomechanics of Valencia and Progénika Biopharma S.A. are also participating.
In the case of substantial deterioration of the bone, it may be necessary for the implant to provide both functional and physiological properties of the damaged item. Given this hypothesis, the bone implants have to comply with a series of requisites capable of contributing to a reconstruction of the deteriorated bone tissue in the most efficient and least discomfiting manner, without any serious repercussion. Another exigency involves the carrying out of the mechanical functions of the damaged bone while the desired regeneration takes place.
The solutions have to be capable, moreover, of remedying particularly serious damage, such as those due to congenital deficiencies, degenerative illnesses, cancerous disorders and other damage caused by accidents. The implants required for this type of solutions are more complex and sophisticated than the small implants known to date. .
The Nanobiocom project aims at developing a support matrix (scaffold) of a compound material that is ‘intelligent’, proactive, and capable of repairing and regenerating bone tissue. To this end, it has to be bioactive, capable of acting on the tissue-generating system and its corresponding genes, as well as respond appropriately to the physiological and biological changes, both internal and external, of that system.
Also necessary are size and shape characteristics, as well as mechanical functions appropriate to healthy bones.
The specific tasks of the project focus on putting the finishing touches to the intelligent material, based on nanoparticles and of a biodegradable nature. Also to be developed is the cell culture in three dimensions, as well as ensuring the biocompatibility of the material.
Egoitz Etxebeste | basqueresearch
New insight into the brain’s hidden depths: Jena scientists develop minimally-invasive endoscope
27.11.2018 | Leibniz-Institut für Photonische Technologien e. V.
New China and US studies back use of pulse oximeters for assessing blood pressure
21.11.2018 | University of British Columbia
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Materials Sciences
19.12.2018 | Materials Sciences
19.12.2018 | Life Sciences